Andrew Fowler

Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial

Laurie A. Lee, Zelie Bailes, Neil Barnes et al. · The Lancet Respiratory Medicine · 2020 · 239 citations · Full text

Asthma, Pulmonary Care, Allergy +5

Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment

Ian P. Hall, Andrew Fowler, Abhya Gupta et al. · Pulmonary Pharmacology & Therapeutics · 2015 · 84 citations · Full text

Control of the Tissue Inhibitor of Metalloproteinases–1 Promoter in Culture–Activated Rat Hepatic Stellate Cells: Regulation by Activator Protein–1 Dna Binding Proteins

Mathias Bähr, Karen J. Vincent, Michael J.P. Arthur et al. · Hepatology · 1999 · 83 citations · Full text

A randomized study of BI 671800, a CRTH2 antagonist, as add-on therapy in poorly controlled asthma

David Miller, Chester C. Wood, Eric D. Bateman et al. · Allergy and Asthma Proceedings · 2017 · 27 citations

Clinic vs Home Spirometry for Monitoring Lung Function in Patients With Asthma

John Oppenheimer, Nicola A. Hanania, Rekha Chaudhuri et al. · CHEST Journal · 2023 · 26 citations · Full text